Proteinases and inhibitors
- PMID: 7552071
- DOI: 10.1093/oxfordjournals.bmb.a072968
Proteinases and inhibitors
Abstract
The primary agents responsible for cartilage and bone destruction in joint diseases are active proteinases degrading collagen and proteoglycan. All four main classes of proteolytic enzymes are involved in either the normal turnover of connective tissue or its pathological destruction. These proteinases are made by different cells found within the joints. Both extracellular and intracellular pathways exist and individual enzymes can be inhibited by specific proteinaceous inhibitors that block their activity. Recent research has implicated the matrix metalloproteinases (MMPs) in many of the processes involved in joint diseases. Conventional treatments do little to affect the underlying disease processes and recently the use of proteinase inhibitors has been suggested as a new therapeutic approach. Inhibitors of proteinases can prevent the destruction of animal cartilage in model systems and future patient trials will test the effectiveness of these compounds in vivo.
Similar articles
-
Collagenase: a key enzyme in collagen turnover.Biochem Cell Biol. 1996;74(6):759-75. doi: 10.1139/o96-083. Biochem Cell Biol. 1996. PMID: 9164646 Review.
-
Metalloproteinase inhibitors and the prevention of connective tissue breakdown.Pharmacol Ther. 1996;70(3):163-82. doi: 10.1016/0163-7258(96)00015-0. Pharmacol Ther. 1996. PMID: 8888065 Review.
-
A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. Purification and characterization.J Biol Chem. 1986 Oct 25;261(30):14245-55. J Biol Chem. 1986. PMID: 3095317
-
Intercellular messengers in joint tissues in rheumatoid arthritis. How disturbed control mechanisms may contribute to tissue destruction and repair.Scand J Rheumatol Suppl. 1981;40:75-87. Scand J Rheumatol Suppl. 1981. PMID: 6100920
-
Understanding the role of tissue degrading enzymes and their inhibitors in development and disease.Best Pract Res Clin Rheumatol. 2006 Oct;20(5):983-1002. doi: 10.1016/j.berh.2006.06.007. Best Pract Res Clin Rheumatol. 2006. PMID: 16980219 Review.
Cited by
-
Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system.Biochem J. 2000 Feb 1;345 Pt 3(Pt 3):511-9. Biochem J. 2000. PMID: 10642509 Free PMC article.
-
The effect of suramin on the resorption of bovine nasal cartilage.Inflammopharmacology. 1999;7(4):387-400. doi: 10.1007/s10787-999-0032-x. Inflammopharmacology. 1999. PMID: 17657441
-
Expression of tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma.Korean J Intern Med. 2000 Dec;15(3):171-8. doi: 10.3904/kjim.2000.15.3.171. Korean J Intern Med. 2000. PMID: 11242804 Free PMC article.
-
Growth and repair factors, osteoactivin, matrix metalloproteinase and heat shock protein 72, increase with resolution of inflammation in musculotendinous tissues in a rat model of repetitive grasping.BMC Musculoskelet Disord. 2016 Jan 18;17:34. doi: 10.1186/s12891-016-0892-3. BMC Musculoskelet Disord. 2016. PMID: 26781840 Free PMC article.
-
Nuclear hormone receptors inhibit matrix metalloproteinase (MMP) gene expression through diverse mechanisms.Gene Expr. 1996;6(4):197-207. Gene Expr. 1996. PMID: 9196075 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical